检索

标题
作者
Solitary metastasis of colorectal cancer in the left adrenal gland 4 years after surgery on the primary tumor. Case report
Budurova M., Trifanov V., Kopylov V., Kuznetsova O., Chernichenko M., Poluektov S.
Which faecal blood test is more accurate in detecting bowel cancer and large polyps in population screening? (Russian Translation of Cochrane Plain Language Summary (PLS))
Plyakhina K.
Colon cancer-induced sarcopenia: clinical and radiological correlations
Lyadov V., Fedorinov D., Lyadova M., Khristenko E., Boldyreva T., Galkin V.
Avastin in clinical chemotherapy of malignant tumors
Gorbunova V.
The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review
Rykov I., Chubenko V.
Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON
Tryakin A., Fedyanin M., Moiseenko F., Mironov O., Stroyakovskiy D., Sokolov N., Orlova S., Mantsyrev E., Sultanbaev A., Teterich A., Babina K., Yukalchuk D., Borzyanitsa S., Isyangulova A., Saidullaeva A., Chernova Y., Bobrova E., Fadeeva N., Chobanu D.
Laparoscopic resections of the liver and the colon in patients with synchronous colorectal metastases: a case series
Lyadov V., Moskalenko A., Britskaia N.
The possibilities of therapy of patients with metastatic colorectal cancer with BRAF V600E mutation. Clinical cases
Polyanskaya E., Fedyanin M.
The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program
Poddubnaya I., Bichurina S., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Petrukhnenko V., Sivunova I., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.
Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
Sekacheva M., Nuriev R., Rozhkov A., Semenkov A., Bagmet N., Boroda A.
Regorafenib in metastatic colorectal cancer: more data for clinical decisions
Petkau V., Karimova A., Akishina Z.
Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers
Stilidi I., Kotyukova A., Lyadov V.
Assessment and correction of the geriatric status of patients with metastatic colorectal cancer during the first-line systemic therapy
Alekseeva Y., Semiglazova T., Sharashenidze S., Tkachenko E., Kasparov B., Brish N., Teletaeva G., Filatova L., Sluzhev M., Semiglazov V., Protsenko S., Belyaev A.
Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer
Kit O., Vladimirova L., Abramova N., Storozhakova A., Popova I., Tikhanovskaya N., Lyaynova A., Ryadinskaya L.
New aspects of the first-line chemotherapy in colorectal cancer
Artamonova E.
Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy
Kononenko I., Snegovoy A., Grebennikova O., Sel’chuk V., Palchinskaia O.
Regorafenib application in patients with metastatic colorectal cancer in actual clinical practice
Sekacheva M., Bagmet N.
Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases
Sekacheva M., Bagmet N., Polishchuk L., Glazova O., Zaklyazminskaya E., Skripenko O.
The role of regorafenib in the treatment of metastatic colorectal cancer
Tryakin A.
The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion
Bagmet N., Bedzhanyan A., Polishchuk L., Sekacheva M., Shatveryan G., Skipenko O.
Molecular-biological marker Bcl-2 in colorectal cancer: the characteristics, the role of mechanisms regulating apoptosis, the effect on the prognosis (review of literature)
Darenskaia A., Dobrova N., Stepanova E.
The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options
Artamonova E., Manzyuk L.
Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice
Poddubnaya I., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.
The use of regorafenib in colorectal cancer
Sekacheva M., Bagmet N., Guryanova A., Rashi D.
Modern possibilities of targeted therapy in metastatic colorectal cancer
Gorbunova V.
Effect of starting dose of regorafenib on overall survival of patients with metastatic colorectal cancer: a systematic review and meta-analysis
Fedyanin M., Polyanskaya E., Tryakin A., Pokataev I., Tjulandin S.
Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic
Sekacheva M., Fatyanova A., Meretukov D., Zhilenkova A., Rusanov A., Rozhkov A., Guryanova A., Bagmet N.
Clinical cases of the treatment of metastatic colorectal cancer in Russia
Goldberg V., Hasanova A., Shkuratova V., Belevich Y., Popova N., Simolina E., Vysockaya V., Dudnikova E., Kravchuk T., Minnabetdinova R., Nekrasova O.
Radiological diagnostics of colorectal cancer liver metastases and immunohistochemical characteristics after drug treatment
Skipenko T., Paltseva E., Sekacheva M., Bedganian A.
1 - 29 的 29 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##